Login / Register
MS Validated Antibodies - Logo
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
×

Cancer Tissue Gallery AIF 1

Path Created with Sketch.
Go to AIF 1 Normal Tissue GalleryGo back to Product Page
Esophagus - Abundant AIF1 positive inflammatory cells in an adenocarcinoma.
Esophagus - Abundant AIF1 positive inflammatory cells in an adenocarcinoma.
Esophagus – Abundant AIF1 positive inflammatory cells in an adenocarcinoma.
Esophagus - Copious AIF1 positive inflammatory cells in a squamous cell carcinoma.
Esophagus - Copious AIF1 positive inflammatory cells in a squamous cell carcinoma.
Esophagus – Copious AIF1 positive inflammatory cells in a squamous cell carcinoma.
Kidney - Clear cell renal cell carcinoma containing abundant AIF1 positive inflammatory cells.
Kidney - Clear cell renal cell carcinoma containing abundant AIF1 positive inflammatory cells.
Kidney – Clear cell renal cell carcinoma containing abundant AIF1 positive inflammatory cells.
Lung - Adenocarcinoma displaying abundant AIF1 positive inflammatory cells.
Lung - Adenocarcinoma displaying abundant AIF1 positive inflammatory cells.
Lung – Adenocarcinoma displaying abundant AIF1 positive inflammatory cells.
Lung - Malignant mesothelioma (epitheloid subtype) containing abundant AIF1 positive inflammatory cells.
Lung – Malignant mesothelioma (epitheloid subtype) containing abundant AIF1 positive inflammatory cells.
Lung - Squamous cell carcinoma containing numerous AIF1 positive inflammatory cells.
Lung - Squamous cell carcinoma containing numerous AIF1 positive inflammatory cells.
Lung – Squamous cell carcinoma containing numerous AIF1 positive inflammatory cells.
Lymph node - Diffuse large B-cell lymphoma containing a large number of AIF1 positive inflammatory cells.
Lymph node - Diffuse large B-cell lymphoma containing a large number of AIF1 positive inflammatory cells.
Lymph node – Diffuse large B-cell lymphoma containing a large number of AIF1 positive inflammatory cells.
Lymph node - Diffuse large B-cell lymphoma containing various AIF1 positive inflammatory cells.
Lymph node - Diffuse large B-cell lymphoma containing various AIF1 positive inflammatory cells.
Lymph node – Diffuse large B-cell lymphoma containing various AIF1 positive inflammatory cells.
Lymph node - Follicular B-cell lymphoma containing many AIF1 positive inflammatory cells.
Lymph node - Follicular B-cell lymphoma containing many AIF1 positive inflammatory cells.
Lymph node – Follicular B-cell lymphoma containing many AIF1 positive inflammatory cells.
Lymph node - Hodgkin’s lymphoma almost completely consisting of AIF1 positive inflammatory cells. Note: Hodgkin’s and Reed Sternberg cells are AIF1 negative.
Lymph node - Hodgkin’s lymphoma almost completely consisting of AIF1 positive inflammatory cells. Note: Hodgkin’s and Reed Sternberg cells are AIF1 negative.
Lymph node – Hodgkin’s lymphoma almost completely consisting of AIF1 positive inflammatory cells. Note: Hodgkin’s and Reed Sternberg cells are AIF1 negative.
Malignant mesothelioma (epitheloid subtype) containing numerous AIF1 positive inflammatory cells.
Malignant mesothelioma (epitheloid subtype) containing numerous AIF1 positive inflammatory cells.
Oral cavity - Squamous cell carcinoma containing abundant AIF1 positive macrophages and also granulocytes.
Oral cavity - Squamous cell carcinoma containing abundant AIF1 positive macrophages and also granulocytes.
Oral cavity – Squamous cell carcinoma containing abundant AIF1 positive macrophages and also granulocytes.
Ovary - Endometroid carcinoma containing various AIF1 positive inflammatory cells.
Ovary – Endometroid carcinoma containing various AIF1 positive inflammatory cells.
Ovary - Serous high-grade carcinoma including various AIF1 positive inflammatory cells.
Ovary - Serous high-grade carcinoma including various AIF1 positive inflammatory cells.
Ovary – Serous high-grade carcinoma including various AIF1 positive inflammatory cells.
Pancreas - Neuroendocrine tumor containing several AIF1 positive inflammatory cells.
Pancreas – Neuroendocrine tumor containing several AIF1 positive inflammatory cells.
Pancreas - Numerous AIF1 positive inflammatory cells in a ductal adenocarcinoma.
Pancreas – Numerous AIF1 positive inflammatory cells in a ductal adenocarcinoma.
Penis - Squamous cell carcinoma containing various AIF1 positive inflammatory cells.
Penis - Squamous cell carcinoma containing various AIF1 positive inflammatory cells.
Penis – Squamous cell carcinoma containing various AIF1 positive inflammatory cells.
Prostate - Adenocarcinoma (Gleason 3+3=6) displaying only a few AIF1 positive inflammatory cells.
Prostate – Adenocarcinoma (Gleason 3+3=6) displaying only a few AIF1 positive inflammatory cells.
Salivary gland - Many AIF1 positive inflammatory cells in a Warthin tumor.
Salivary gland – Many AIF1 positive inflammatory cells in a Warthin tumor.
Skin - Merkel cell carcinoma containing multiple AIF1 positive inflammatory cells.
Skin - Merkel cell carcinoma containing multiple AIF1 positive inflammatory cells.
Skin – Merkel cell carcinoma containing multiple AIF1 positive inflammatory cells.
Soft tissue - Abundant AIF1 positive inflammatory cells in a liposarcoma.
Soft tissue – Abundant AIF1 positive inflammatory cells in a liposarcoma.
Soft tissue - Abundant AIF1 positive macrophages in a giant cell tumor of the tendon sheath.
Soft tissue – Abundant AIF1 positive macrophages in a giant cell tumor of the tendon sheath.
Soft tissue - Leiomyosarcoma containing numerous AIF1 positive inflammatory cells.
Soft tissue – Leiomyosarcoma containing numerous AIF1 positive inflammatory cells.
Soft tissue - Sarcoma NOS containing abundant AIF1 positive inflammatory cells.
Soft tissue – Sarcoma NOS containing abundant AIF1 positive inflammatory cells.
Stomach - Gastric adenocarcinoma containing numerous AIF1 positive inflammatory cells.
Stomach - Gastric adenocarcinoma containing numerous AIF1 positive inflammatory cells.
Stomach – Gastric adenocarcinoma containing numerous AIF1 positive inflammatory cells.
Stomach - Gastrointestinal stromal tumor (GIST) containing various AIF1 positive inflammatory cells.
Stomach – Gastrointestinal stromal tumor (GIST) containing various AIF1 positive inflammatory cells.
Testis - Leydig cell tumor showing numerous intermingled AIF1 positive inflammatory cells.
Testis - Leydig cell tumor showing numerous intermingled AIF1 positive inflammatory cells.
Testis – Leydig cell tumor showing numerous intermingled AIF1 positive inflammatory cells.
Testis - Seminoma containing numerous AIF1 positive inflammatory cells.
Testis – Seminoma containing numerous AIF1 positive inflammatory cells.
Thyroid - Papillary carcinoma containing only a few AIF1 positive inflammatory cells.
Thyroid – Papillary carcinoma containing only a few AIF1 positive inflammatory cells.
Urinary bladder - Muscle-invasive urothelial carcinoma containing numerous AIF1 positive inflammatory cells.
Urinary bladder – Muscle-invasive urothelial carcinoma containing numerous AIF1 positive inflammatory cells.
Uterus, cervix - Squamous cell carcinoma containing many AIF1 positive inflammatory cells.
Uterus, cervix – Squamous cell carcinoma containing many AIF1 positive inflammatory cells.
  • Linkedin
  • My Account
  • Search
    ×
  • Cart 0
© 2025 MS Validated Antibodies
  • Imprint
  • Privacy Policy
  • Distributors